智通财经网·2025-09-01 01:43Core Viewpoint - Spring Medical (01858) reported a significant increase in both revenue and net profit for the first half of 2025, indicating strong operational performance and market expansion efforts [1] Financial Performance - The company's revenue reached approximately 488 million yuan, representing a year-on-year growth of 28.27% [1] - The net profit attributable to shareholders was around 114 million yuan, showing a year-on-year increase of 44.85% [1] Growth Drivers - Revenue growth was primarily driven by stable supply of centralized procurement products and continuous sales growth [1] - The company is steadily advancing its international market expansion, with export business continuing to rise [1] - Net profit growth is attributed to stable supply of centralized procurement products, deepening international market development, and internal cost reduction and efficiency enhancement [1]